Transforming growth factor β affects osteoclast differentiation via direct and indirect actions

Journal of Bone and Mineral Research

Volumn 16, Issue 10, 2001, Pages 1787-1794

  Quinn, J M W ^a   Itoh, K ^a   Udagawa, N ^a   Hausler K ^a   Yasuda, H ^a   Shima, N ^a   Mizuno, A ^a   Higashio, K ^a   Takahashi, N ^a   Suda, T ^a   Martin, T J ^a   Gillespie, M T ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Osteoclasts; Osteoprotegerin; Receptor activator of nuclear factor B ligand; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL KINETICS; CELL MATURATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; HEMATOPOIETIC CELL; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STEM CELL;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; GLYCOPROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034813516     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.10.1787     Document Type: Article

References (43)

1. Transforming growth factor beta
2. Regulation and regulatory activities of transforming growth factor beta
3. Plasminogen-dependent activation of latent transforming growth factor beta by growing cultures of osteoblast-like cells
4. Activation of bone derived latent TGF-β complex by isolated osteoclasts
5. Stimulation of bone formation in vivo by transforming growth factor-beta: Remodeling of woven bone and lack of inhibition by indomethacin
6. Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
7. Increased expression of TGF-β 2 in osteoblasts results in an osteoporosis-like phenotype
8. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures
9. Role of transforming growth factor-β in bone remodeling
10. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats
11. Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function
12. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
14. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
15. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
16. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
17. Activated T lymphocytes support osteoclast formation in vitro
18. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
19. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
20. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
21. TGF-β enhances osteoclast differentiation in haemopoietic cell cultures stimulated with RANKL and M-CSF
22. Activin A is an essential cofactor for osteoclast induction
23. Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
24. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
25. IL-6 induction of osteoclast differentiation depends upon IL-6 receptors expressed on osteoblastic cells, but not on osteoclast progenitors
26. Interleukin 18 inhibits osteoclast formation via T-cell production of granulocyte-macrophage colony stimulating factor
27. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
28. Abundant calcitonin receptors in isolated rat osteoclasts
29. Resorption of bone by isolated rabbit osteoclasts
30. Macrophage colony stimulating factor is indispensible for both proliferation and differentiation of osteoclast progenitors
31. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
32. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
33. Osteoclast inhibitory factor (OCIF) directly inhibits bone resorbing activity of isolated mature osteoclasts
34. Interleukins in the control of osteoclast differentiation
35. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANKL ligand
36. A role for TGFβ(1) in osteoclast differentiation and survival
37. Expression of functional RANK on mature rat and human osteoclasts
38. Required and nonessential functions of nuclear factor-kappa B in bone cells
39. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
40. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappaB ligand (RANKL)
41. Differential induction of cytokine genes and activation of mitogen-activated protein kinase family by soluble CD40 ligand and TNF in a human follicular dendritic cell line
42. Transforming growth factor beta1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages
43. Smads bind directly to the Jun family of AP-1 transcription factors